Mediwound Valuation
| MDWD Stock | USD 19.50 0.83 4.08% |
At this time, the firm appears to be undervalued. Mediwound secures a last-minute Real Value of $23.87 per share. The latest price of the firm is $19.5. Our model forecasts the value of Mediwound from analyzing the firm fundamentals such as Profit Margin of (0.99) %, return on equity of -0.76, and Current Valuation of 180.26 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mediwound's valuation include:
Price Book 6.4075 | Enterprise Value | Enterprise Value Ebitda (6.32) | Price Sales 10.8913 | Enterprise Value Revenue 9.1409 |
Undervalued
Today
Please note that Mediwound's price fluctuation is not too volatile at this time. Calculation of the real value of Mediwound is based on 3 months time horizon. Increasing Mediwound's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mediwound stock is determined by what a typical buyer is willing to pay for full or partial control of Mediwound. Since Mediwound is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mediwound Stock. However, Mediwound's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.5 | Real 23.87 | Target 29.0 | Hype 19.5 |
The real value of Mediwound Stock, also known as its intrinsic value, is the underlying worth of Mediwound Company, which is reflected in its stock price. It is based on Mediwound's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mediwound's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mediwound helps investors to forecast how Mediwound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mediwound more accurately as focusing exclusively on Mediwound's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mediwound's intrinsic value based on its ongoing forecasts of Mediwound's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mediwound's closest peers. If more than one evaluation category is relevant for Mediwound we suggest using both methods to arrive at a better estimate.
Mediwound Cash |
|
Mediwound Valuation Trend
Comparing Mediwound's enterprise value against its market capitalization is a good way to estimate the value of Mediwound uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Mediwound Total Value Analysis
Mediwound is now anticipated to have valuation of 180.26 M with market capitalization of 219.36 M, debt of 6.35 M, and cash on hands of 10.41 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mediwound fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
180.26 M | 219.36 M | 6.35 M | 10.41 M |
Mediwound Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.91. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022. Based on the measurements of operating efficiency obtained from Mediwound's historical financial statements, Mediwound is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Mediwound Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mediwound has an asset utilization ratio of 28.12 percent. This indicates that the Company is making $0.28 for each dollar of assets. An increasing asset utilization means that Mediwound is more efficient with each dollar of assets it utilizes for everyday operations.Mediwound Ownership Allocation
The market capitalization of Mediwound is $219.36 Million. 30% of Mediwound outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Mediwound Profitability Analysis
The company reported the previous year's revenue of 18.69 M. Net Loss for the year was (6.72 M) with profit before overhead, payroll, taxes, and interest of 2.67 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mediwound's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mediwound and how it compares across the competition.
About Mediwound Valuation
The stock valuation mechanism determines Mediwound's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mediwound. We calculate exposure to Mediwound's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mediwound's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4.1 M | 5 M | |
| Pretax Profit Margin | (0.31) | (0.33) | |
| Operating Profit Margin | (0.74) | (0.77) | |
| Net Loss | (0.32) | (0.34) | |
| Gross Profit Margin | 0.17 | 0.18 |
Mediwound Growth Indicators
Investing in growth stocks can be very risky. If the company such as Mediwound does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9 M |
Mediwound Current Valuation Indicators
Valuation refers to the process of determining the present value of Mediwound and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mediwound we look at many different elements of the entity such as Mediwound's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mediwound, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mediwound's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mediwound's worth.Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |